文献速递瓣膜外科

主动脉瓣置换同期外科消融对房颤患者长期生存的影响

Surgical Ablation of Pre-Existing Atrial Fibrillation During Aortic Valve Replacement in Medicare Beneficiaries.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该回顾性队列研究基于2008-2019年Medicare索赔数据,纳入37 666例合并房颤的主动脉瓣置换患者,仅22.6%同期接受外科消融。

要点

  • 合并房颤的主动脉瓣置换患者中,同期外科消融使用率仅22.6%。
  • 由高频消融术者手术与生存时间延长2.3个月相关。

核心结论

  • 在合并房颤的Medicare受益者中,主动脉瓣置换同期外科消融与临床幅度有限的晚期生存优势相关。
  • 由高频消融术者手术亦与晚期生存优势相关。

研究设计与样本

  • 回顾性队列研究,查询2008-2019年Medicare索赔数据,纳入37 666例合并房颤的主动脉瓣置换患者。
  • 以术者消融频率作为工具变量重新分析结局,所有分析均采用重叠倾向评分加权进行风险调整。

主要发现

  • 37 666例中仅8 499例(22.6%)接受同期外科消融。
  • 风险调整后RMST在消融组与未消融组分别为6.59年与6.21年,差异4.6个月(P < 0.001)。
  • 按术者消融频率分组,高频组与低频组风险调整后RMST分别为6.14年与5.94年,差异2.3个月(P = 0.03)。

临床怎么用

  • 对合并房颤的主动脉瓣置换患者,可考虑同期外科消融以改善晚期生存,但绝对获益幅度有限。
  • 术者消融经验可能与患者预后相关,提示开展该手术需关注技术熟练度。

局限性

  • 原文摘要未报告具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Guidelines recommend surgical ablation (SA) during isolated aortic valve replacement (AVR) in patients with pre-existing atrial fibrillation (AF). Nevertheless, SA remains underutilized during AVR, and the impact of SA on long-term outcomes is poorly quantified. We examined the association of SA with survival and the incidence of stroke or transient ischaemic attack (TIA) in Medicare beneficiaries with AF undergoing AVR. METHODS: Medicare claims (2008-2019) were queried to identify patients with AF undergoing AVR; procedural characteristics were doubly adjudicated using hospital and surgeon billing codes. Kaplan-Meier survival estimates were generated for beneficiaries who did and did not receive concomitant SA. Ten-year restricted mean survival times (RMST) were compared; 95% confidence intervals are provided. Outcomes were re-analysed using surgeon frequency of SA as an instrumental variable. Overlap propensity score weighting was performed for risk-adjustment in all analyses. RESULTS: Among 37 666 beneficiaries with AF undergoing AVR, only 8499 (22.6%) underwent SA. Surgeons were categorized by quartile of SA frequency during AVR: 1318 infrequently performed SA (<7.5% of cases; 9438 beneficiaries), whereas 786 frequently performed SA (≥34%; 9353 beneficiaries). Risk-adjusted RMSTs were 6.59 [6.49-6.69] vs 6.21 [6.11-6.31] years in beneficiaries with and without concomitant SA during AVR, a difference of 4.6 [1.8-7.4] months (P < 0.001). Risk-adjusted RMSTs were 6.14 [6.01-6.26] vs 5.94 [5.82-6.06] years for beneficiaries undergoing AVR by frequent and infrequent SA surgeons, a difference of 2.3 [0.2, 4.4] months (P = 0.03). CONCLUSIONS: In Medicare beneficiaries with AF undergoing AVR, utilization of concomitant SA was associated with a clinically modest late survival advantage, as was undergoing surgery by a frequent SA surgeon.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. McCullough KA, Eisenga JB, Banwait JK, et al. Surgical Ablation of Pre-Existing Atrial Fibrillation During Aortic Valve Replacement in Medicare Beneficiaries. Eur J Cardiothorac Surg. 2025. PMID: 40828903. doi:10.1093/ejcts/ezaf278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。